Daniel Virnich Biography and Net Worth

CEO of Oncology Institute

Dr. Daniel Virnich joined The Oncology Institute in 2020. As Chief Executive Officer, Dr. Virnich believes in focusing on clinician and teammate culture as a key to driving great oncology care and the best patient outcomes.

Before joining The Oncology Institute, Dr. Virnich was the President of DaVita Medical Group, Florida. In that role, Dr. Virnich managed a full-risk medical group and IPA with over 1,400 teammates and clinicians accountable for over 92,000 Medicare Advantage members. Prior to running HCP’s Florida Market, Dr. Virnich was Senior Vice President of Operations for Healthcare Partners in Southern California.

Earlier in his career, he was the Chief Medical Officer for Team Health’s Acute Care services division. Dr. Virnich received his BA and MD from the University of Chicago and his MBA from Northwestern University. He completed his residency in Internal Medicine at UCLA and is a Fellow of the American College of Healthcare Executives.

What is Daniel Virnich's net worth?: The estimated net worth of Daniel Virnich is at least $2.34 million as of March 26th, 2025. Dr. Virnich owns 724,363 shares of Oncology Institute stock worth more than $2,339,692 as of December 5th. This net worth approximation does not reflect any other investments that Dr. Virnich may own. Additionally, Dr. Virnich receives an annual salary of $614,620.00 as CEO at Oncology Institute. Learn More about Daniel Virnich's net worth.
How old is Daniel Virnich?: Dr. Virnich is currently 45 years old. There are 4 older executives and no younger executives at Oncology Institute. Learn More on Daniel Virnich's age.
What is Daniel Virnich's salary?: As the CEO of The Oncology Institute, Inc., Dr. Virnich earns $614,620.00 per year. Learn More on Daniel Virnich's salary.
How do I contact Daniel Virnich?: The corporate mailing address for Dr. Virnich and other Oncology Institute executives is 345 PARK AVENUE SOUTH, NEW YORK NY, 10010. Oncology Institute can also be reached via phone at 562-735-3226 and via email at [email protected]. Learn More on Daniel Virnich's contact information.
Has Daniel Virnich been buying or selling shares of Oncology Institute?: Daniel Virnich has not been actively trading shares of Oncology Institute within the last three months. Most recently, on Wednesday, March 26th, Daniel Virnich bought 22,640 shares of Oncology Institute stock. The stock was acquired at an average cost of $1.04 per share, with a total value of $23,545.60. Following the completion of the transaction, the chief executive officer now directly owns 724,363 shares of the company's stock, valued at $753,337.52. Learn More on Daniel Virnich's trading history.
Who are Oncology Institute's active insiders?: Oncology Institute's insider roster includes Yale Podnos (Director), and Daniel Virnich (CEO). Learn More on Oncology Institute's active insiders.
Are insiders buying or selling shares of Oncology Institute?: In the last year, Oncology Institute insiders bought shares 3 times. They purchased a total of 122,258 shares worth more than $127,148.32. In the last year, insiders at the sold shares 8 times. They sold a total of 11,476,137 shares worth more than $34,282,013.19. The most recent insider tranaction occured on November, 18th when Director Mark L Pacala sold 50,000 shares worth more than $200,000.00. Insiders at Oncology Institute own 8.5% of the company. Learn More about insider trades at Oncology Institute.
Information on this page was last updated on 11/18/2025.

Daniel Virnich Insider Trading History at Oncology Institute

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/26/2025	Buy	22,640	$1.04	$23,545.60	724,363

Daniel Virnich Buying and Selling Activity at Oncology Institute

Oncology Institute Company Overview

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Today's Range

Now: $3.23

$3.06

$3.32

50 Day Range

MA: $3.75

$2.94

$4.75

2 Week Range

Now: $3.23

$0.17

$4.88

Volume

2,000,460 shs

Average Volume

3,045,784 shs

Market Capitalization

$317.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.16

Daniel Virnich Biography and Net Worth

What is Daniel Virnich's net worth?

How old is Daniel Virnich?

What is Daniel Virnich's salary?

How do I contact Daniel Virnich?

Has Daniel Virnich been buying or selling shares of Oncology Institute?

Who are Oncology Institute's active insiders?

Are insiders buying or selling shares of Oncology Institute?